Company: SLNH
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023503
Chunk: 179

Company: Soluna Holdings, Inc
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 8
Chunk 179
---
.70 warrants.

The
following table represents the significant fair value assumptions used for warrants issued or repriced during the year ended December
31, 2024. No warrants were issued or repriced for the three and nine months ended September 30, 2025 in relation to the warrants issued
in conjunction with convertible notes.

Schedule of Fair Value Assumptions For Warrants Issued

    Year
                                            ended  December
                                            31, 2024 

    Stock price 
    $2.43-
                                            4.07 

    Exercise price 
    $0.01-
                                            287.50 

    Expected term in years 
     0.53
                                            – 8.77 

    Expected dividend yield 
     0.00%

    Volatility 
     105.0
                                            – 137.50%

    Risk-free interest rate 
     3.51-
                                            4.44%

    24

As
previously discussed in Footnote 1, the Company entered into the SEPA with YA on August 12, 2024. Access to the SEPA was subject to a
number of conditions precedent including, but not limited to, various consents from the Company’s Note Holders. On October 1, 2024,
the Noteholders entered into a Consent, Waiver, and Mutual Release Agreement (the “Master Consent”) which provides the following:

    ●
    consent
    to the Company’s entry into the SEPA;

    ●
    waiver
    of any rights of first refusal or participation rights in connection with the SEPA;

    ●
    standstill
    of the rights to exercise certain $0.01 warrants pursuant to the SPA;

    ●
    the
    right to prepay the convertible notes with a 20% premium;

    ●
    termination
    of the SPA and related agreements upon the full payoff of the convertible notes; and

    ●
    mutual
    limited release of claims between the Noteholders and the Company.

In
return for these consents, the Company agreed to pay a $750 thousand waiver fee and to prepay to the remaining Note Holders the 20% premium
for the prepayment of the Notes of approximately $625 thousand. Such amounts were recorded as within Other Expense, net for the year
ended December 31, 2024.

For
the year ended December 31, 2024, the Company issued